By Matt Kelly2005-08-23T00:00:00
2016-03-15T14:45:00Z By David Bogoslaw
Valeant Pharmaceuticals’ announced financial restatement raises questions about the drug company’s compliance program and its business model. But it might also serve as an early warning to all publicly listed U.S. companies about the increased room for misjudging the booking of sales once FASB rolls out its new revenue recognition ...
2025-08-07T14:00:00Z Provided by ProcessUnity
Don’t miss this opportunity to prepare your organization for the future of TPRM and stay ahead with AI as your second-in-command.
2025-07-31T16:44:00Z By Adrianne Appel
Kentucky took aim at Chinese company Temu, alleging in a lawsuit that it counterfeited popular Kentucky-designed merchandise and violated customers’ privacy.
Site powered by Webvision Cloud